Search results for "Meta-"

showing 10 items of 1069 documents

Bone mineral density, osteoporosis, and fractures among people with eating disorders: a systematic review and meta-analysis

2016

Objective: To provide meta-analytical evidence of bone mineral density (BMD), fractures, and osteoporosis rates in eating disorders (ED) vs. healthy controls (HCs). Method: Three independent authors searched major electronic databases from inception till August 2015 for cross-sectional studies reporting BMD in people with ED (anorexia nervosa, (AN); bulimia nervosa, (BN); eating disorders not otherwise specified, (EDNOS)) vs. HCs. Standardized mean differences (SMDs) ±95% and confidence intervals (CIs) were calculated for BMD, and odds ratios (ORs) for osteopenia, osteoporosis, and fractures. Results: Overall, 57 studies were eligible, including 21 607 participants (ED = 6485, HCs = 15 122)…

medicine.medical_specialtyBone densityOsteoporosis030209 endocrinology & metabolismComorbidityFeeding and Eating Disorderseating disorders (ED)Fractures Bone03 medical and health sciences0302 clinical medicineBone DensityInternal medicinemedicineHumans030212 general & internal medicineFemoral neckBulimia nervosabusiness.industryAnorexia nervosaOdds ratiomedicine.diseaseOsteopeniaPsychiatry and Mental healthEating disordersmedicine.anatomical_structureBulimia nervosaosteoporosis rateEating disordersPhysical therapyOsteoporosisAmenorrheamedicine.symptomAnorexia nervosa; Bone density; Bulimia nervosa; Eating disorders; Fractures; Psychiatry and Mental Healthbusinessmeta-analytical evidence of bonemineral density (BMD)Fracturesanorexia nervosa; bone density; bulimia nervosa; eating disorders; fracturesActa Psychiatrica Scandinavica
researchProduct

Effect of uric acid in animal models of ischemic stroke: A systematic review and meta-analysis

2020

Addition of uric acid (UA) to thrombolytic therapy, although safe, showed limited efficacy in improving patients’ stroke outcome, despite alleged neuroprotective effects of UA in preclinical research. This systematic review assessed the effects of UA on brain structural and functional outcomes in animal models of ischemic stroke. We searched Medline, Embase and Web of Science to identify 16 and 14 eligible rodent studies for qualitative and quantitative synthesis, respectively. Range of evidence met 10 of a possible 13 STAIR criteria. Median (Q1, Q3) quality score was 7.5 (6, 10) on the CAMARADES 15-item checklist. For each outcome, we used standardised mean difference (SMD) as effect size…

medicine.medical_specialtyBrain damageNeuroprotectionMice03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAnimal modelFibrinolytic AgentsInternal medicineStroke outcomeIschaemic strokeAnimalsHumansMedicineThrombolytic TherapyReview ArticlesIschemic Stroke030304 developmental biology0303 health sciencesbusiness.industryRecovery of FunctionRatsUric AcidNeurologychemistryMeta-analysisIschemic strokeCardiologyUric acidNeurology (clinical)Nervous System Diseasesmedicine.symptomCardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgeryJournal of Cerebral Blood Flow & Metabolism
researchProduct

Efficacy of proteolytic enzyme bromelain on health outcomes after third molar surgery. Systematic review and meta-analysis of randomized clinical tri…

2019

Background Bromelain is a cysteine protease isolated from pineapple with a range of biological properties including platelet aggregation inhibition and anti-inflammatory effects. Recent studies have evaluated the clinical implications of bromelain in reducing postoperative inflammatory complications after third molar surgery, but the results are contrasting. This systematic review and meta-analysis evaluated the effects of bromelain on health outcomes in patients submitted to third molar surgery. Material and Methods The study was conducted following the PRISMA statement. Searches were conducted in six electronic databases and Google Scholar from inception to May 2018. The following element…

medicine.medical_specialtyBromelain (pharmacology)PopulationReviewTrismusPlacebolaw.invention03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRandomized controlled triallawInternal medicinemedicineHumans030212 general & internal medicineeducationGeneral DentistryRandomized Controlled Trials as TopicInflammationeducation.field_of_studyPain Postoperativebusiness.industryProteolytic enzymes030206 dentistry:CIENCIAS MÉDICAS [UNESCO]BromelainsTreatment OutcomeOtorhinolaryngologyStrictly standardized mean differenceMeta-analysisUNESCO::CIENCIAS MÉDICASSurgeryMolar Thirdmedicine.symptomOral Surgerybusiness
researchProduct

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

2021

ObjectiveThe benefit of direct-acting antivirals (DAAs) against HCV following successful treatment of hepatocellular carcinoma (HCC) remains controversial. This meta-analysis of individual patient data assessed HCC recurrence risk following DAA administration.DesignWe pooled the data of 977 consecutive patients from 21 studies of HCV-related cirrhosis and HCC, who achieved complete radiological response after surgical/locoregional treatments and received DAAs (DAA group). Recurrence or death risk was expressed as HCC recurrence or death per 100 person-years (100PY). Propensity score-matched patients from the ITA.LI.CA. cohort (n=328) served as DAA-unexposed controls (no-DAA group). Risk fac…

medicine.medical_specialtyCarcinoma HepatocellularCirrhosisAntiviral AgentsGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineantiviral therapymedicineHumansPropensity Scoreantiviral therapy; hepatocellular carcinoma; meta-analysisbusiness.industryLiver NeoplasmsGastroenterologyAntiviral therapyPatient datahepatocellular carcinomamedicine.disease3. Good healthmeta-analysis030220 oncology & carcinogenesisMeta-analysisHepatocellular carcinomaRelative riskCohort030211 gastroenterology & hepatology[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieNeoplasm Recurrence LocalbusinessDirect acting
researchProduct

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma.

2010

Knowing the spontaneous outcome of hepatocellular carcinoma (HCC) is important for designing randomized controlled trials (RCTs) of new therapeutic approaches; however, survival of patients in the absence of treatment is highly variable, and prognostic factors influencing outcomes are incompletely defined. The aims of this meta-analysis were to estimate the 1-year and 2-year survival rates of untreated HCC patients enrolled in RCTs of palliative treatments, and to identify prognostic factors. RCTs evaluating therapies for HCC with placebo or no-treatment arms were identified on MEDLINE through April 2009. Data were combined in a random effect model. Primary outcomes were 1-year and 2-year s…

medicine.medical_specialtyCarcinoma Hepatocellularlaw.inventionRandomized controlled triallawInternal medicinemedicineHumansChemoembolization TherapeuticSurvival rateNeoplasm StagingRandomized Controlled Trials as TopicHepatologyPerformance statusbusiness.industryLiver Neoplasmshepatocellular carcinomaHepatologymedicine.diseaseConfidence intervalSurgerySurvival RateMeta-analysisHepatocellular carcinomaRegression AnalysisLiver cancerbusinessPublication BiasHepatology (Baltimore, Md.)
researchProduct

Osteoarthritis and mortality: a prospective cohort study and systematic review with meta-analysis

2016

Objectives: Osteoarthritis (OA) is a leading cause of disability, but the relationship with premature mortality remains uncertain. We aimed to investigate the relationship between OA and mortality from any cause and from cardiovascular disease (CVD).\ud \ud Methods: Electronic literature databases searches were conducted to identify prospective studies comparing mortality in a sample of people with and without OA. Risk of all-cause and CVD mortality were summarized using adjusted hazard ratios (HRs) for joint specific (hand, hip, and knee) and joint non-specific OA. New data from the Progetto Veneto Anziani (PRO.V.A.) study were also included. Results: From the PRO.V.A. study (N 1⁄4 2927), …

medicine.medical_specialtyCardiovascular disease; Mortality; Osteoarthritis; Rheumatology; Anesthesiology and Pain MedicineOsteoarthritisDiseaseComorbidity03 medical and health sciences0302 clinical medicineRheumatologycardiovascular diseaseRisk FactorsInternal medicineOsteoarthritismedicineHumans030212 general & internal medicineProspective StudiesMortalityProspective cohort study030203 arthritis & rheumatologybusiness.industryHazard ratioOsteoarthritis Mortality Cardiovascular diseasemedicine.diseaseCardiovascular diseaseR1ComorbiditymortalityRheumatologyosteoarthritisIncreased riskAnesthesiology and Pain MedicineCardiovascular DiseasesMeta-analysisPhysical therapybusinessCardiovascular disease; Mortality; Osteoarthritis
researchProduct

Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis

2017

Catatonia is an independent syndrome that co-occurs with several mental and medical conditions. We performed a systematic literature review in PubMed/Scopus until February 2017 and meta-analyzed studies reporting catatonia prevalence. Across 74 studies (cross-sectional = 32, longitudinal = 26, retrospective = 16) providing data collected from 1935 to 2017 across all continents, mean catatonia prevalence was 9.0% (k = 80, n = 110 764; 95% CI = 6.9-11.7, I2 = 98%, publication bias P < .01), decreasing to 7.8% (k = 19, n = 7612, 95% CI = 7-8.7, I2 = 38.9%) in a subgroup with low heterogeneity. Catatonia prevalence was 23.9% (k = 8, n = 1168, 95% CI = 10-46.9, I2 = 96%) in patients undergoin…

medicine.medical_specialtyCatatoniaTranstornos Mentaisprevalencemeta-analysiDSM-503 medical and health sciencesDSM5; catatonia; meta-analysis; prevalence; severe mental illness0302 clinical medicineDSM5catatonia meta-analysis DSM5 severe mental illness prevalenceRating scaleInternal medicinesevere mental illnessmedicineHumansMeta-regressionPsychiatryMental DisordersCatatoniaPublication biasmedicine.disease030227 psychiatrymeta-analysisPsychiatry and Mental healthSample size determinationMeta-analysisMajor depressive disordercatatoniaPsychology030217 neurology & neurosurgeryRegular Articles
researchProduct

Incidence of peripheral intravenous catheter failure and complications in paediatric patients: Systematic review and meta analysis.

2020

Background: Most paediatric patients have at least one peripheral intravenous catheter insertion during their hospitalisation. Despite the important function of peripheral intravenous catheters for delivery of intravenous therapy, failure and complications rates are widely reported; however these results have not been synthesised. Objective: To provide an overall estimate of peripheral intravenous catheter failure and related complications in the paediatric population. Design: Systematic review and meta-analysis Data sources: The electronic databases, Cochrane Central Register of Controlled Trials, US National Library of Medicine National Institutes of Health, Cumulative Index of Nursing an…

medicine.medical_specialtyCatheter insertion030504 nursingbusiness.industrymedicine.medical_treatmentIncidence03 medical and health sciencesCatheter0302 clinical medicineIntravenous therapyAccidentalInternal medicineMeta-analysisOcclusionCatheterization PeripheralMedicineHumansObservational study030212 general & internal medicine0305 other medical sciencebusinessComplicationChildPhlebitisGeneral NursingInternational journal of nursing studies
researchProduct

Interferon for non-A, non-B chronic hepatitis

1991

Abstract We reviewed randomised clinical trials evaluating the effect of lymphoblastoid or recombinant α-interferon in non-A, non-B chronic hepatitis. The outcomes assessed were the rates of serum alanine aminotransferase normalization and relapse during and after stopping interferon. Data were pooled by meta-analysis and a 50% overall rate difference, favouring treated patients, was found. Results showed homogeneity in direction of treatment effect both after short-term (2–6 months, ≥ 2 mega-units thrice weekly) and long-term (9–18 months, variable dose) interferon course. Moreover, results did not change when type of publication (abstracts vs. full reports) and treatment duration or sched…

medicine.medical_specialtyChemotherapyHepatologybusiness.industrymedicine.medical_treatmentSurgeryClinical trialChronic hepatitisInterferonInternal medicineMeta-analysisMedicineDose reductionViral diseaseAlanine aminotransferasebusinessmedicine.drugJournal of Hepatology
researchProduct

Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic form: definitive evidence from meta-ana…

2020

Background Cholangiocarcinoma is a cancer with poor prognosis. The detection of risk factors is fundamental to identify subjects at higher risk of cholangiocarcinoma. Nonalcoholic fatty liver disease (NAFLD) represents a leading cause of chronic liver disease worldwide. Recent data suggested that NAFLD increases the risk of cholangiocarcinoma development. However, it is necessary to better explain the strength of association between NAFLD and cholangiocarcinoma. Methods A systematic research of current case-control, cohort, clinical trial and meta-analysis on the main electronic databases was made. A recent systematic review was recognized. We performed cumulative meta-analyses with sensiti…

medicine.medical_specialtyChronic liver diseasedigestive systemGastroenterologyCholangiocarcinoma03 medical and health sciences0302 clinical medicineNon-alcoholic Fatty Liver DiseaseInternal medicineNonalcoholic fatty liver diseasemedicineHumansIntrahepatic CholangiocarcinomaHepatologybusiness.industryConfoundingLiver NeoplasmsGastroenterologyOdds ratiomedicine.diseasedigestive system diseasesConfidence intervalClinical trialBile Ducts IntrahepaticBile Duct Neoplasms030220 oncology & carcinogenesisMeta-analysisliver Intrahepatic Cholangiocarcinoma extrahepatic Cholangiocarcinoma030211 gastroenterology & hepatologybusiness
researchProduct